Carl T. Berdahl

Jun 6, 2024 | cdc.gov | Carl T. Berdahl

Weekly / June 6, 2024 / 73(22);507–513 Carl T. Berdahl, MD1,2; Anusha Krishnadasan, PhD3; Kavitha Pathmarajah, MPH3; Gregory J. Moran, MD2,3; Jesus R. Torres, MD2,3; Matthew Waxman, MD2,3; William Mower, MD, PhD2,3; Omai B. Garner, PhD2,4; Lorenzo P. Duvergne2,4; Anne W. Rimoin, PhD5; Pamina M. Gorbach, DrPH5; David A.

Mar 19, 2024 | medrxiv.org | Yunwen Wang |Karen O'Connor |Ivan Flores |Carl T. Berdahl

Dr. Graciela Gonzalez-Hernandez is a consultant for F. Hoffmann-La Roche AG (Basel, Switzerland), where she mentors a postdoctoral researcher affiliated with Roche. Dr. Robin Stevens is a consultant for Meta, where she works with the product team in advising and training. Dr. Carl Berdahl has received consulting fees and/or salary support from VisualDx and Infotechsoft, Inc. Other authors declare no conflicts of interest.

Aug 14, 2023 | rand.org | Carl T. Berdahl |Lawrence Baker |Sean Mann |Osonde A. Osoba

BackgroundEmerging artificial intelligence (AI) applications have the potential to improve health, but they may also perpetuate or exacerbate inequities. ObjectiveThis review aims to provide a comprehensive overview of the health equity issues related to the use of AI applications and identify strategies proposed to address them.

Jun 2, 2023 | rand.org | Sean Mann |Carl T. Berdahl |Lawrence Baker |Federico Girosi

This study was prepared for the Patient-Centered Outcomes Research Institute (PCORI) Emerging Technology and Therapeutics Report series. This study, on the use of artificial intelligence (AI) in the COVID-19 response, is the first of 2 reports examining artificial intelligence in health care. Problem Statement Research into AI for health care has grown rapidly in recent years, although adoption has been limited in most domains.